Drug Shortage Report for TEVA-BUDESONIDE

Last updated on 2021-10-14 History
Report ID 140390
Drug Identification Number 02465949
Brand name TEVA-BUDESONIDE
Common or Proper name BUDESONIDE INH 0.125MG/ML 2ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BUDESONIDE
Strength(s) 0.125MG
Dosage form(s) SUSPENSION
Route of administration INHALATION INHALATION
Packaging size 20pk
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-06-02
Estimated end date 2021-10-31
Actual end date 2021-10-13
Shortage status Resolved
Updated date 2021-10-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-10-14 French Compare
v9 2021-10-14 English Compare
v8 2021-10-07 French Compare
v7 2021-10-07 English Compare
v6 2021-08-27 French Compare
v5 2021-08-27 English Compare
v4 2021-07-29 French Compare
v3 2021-07-29 English Compare
v2 2021-06-03 French Compare
v1 2021-06-03 English Compare